Wordt geladen...
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via ac...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer London
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3962576/ https://ncbi.nlm.nih.gov/pubmed/24526250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-014-2517-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|